Xinxin Tian
National Institute of Biological Sciences, Beijing(CN)Tsinghua University(CN)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, T-cell and B-cell Immunology, COVID-19 Clinical Research Studies
Most-Cited Works
- → Tenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical Trial(2025)33 cited
- → A Cross-Species Reactive TIGIT-Blocking Antibody Fc Dependently Confers Potent Antitumor Effects(2020)25 cited
- → An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants(2023)24 cited
- → A cross-reactive pH-dependent EGFR antibody with improved tumor selectivity and penetration obtained by structure-guided engineering(2022)15 cited
- → An anti-CD98 antibody displaying pH-dependent Fc-mediated tumour-specific activity against multiple cancers in CD98-humanized mice(2022)10 cited
- → A CD25×TIGIT bispecific antibody induces anti-tumor activity through selective intratumoral Treg cell depletion(2024)10 cited
- → An IgM-like Inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2(2022)3 cited
- → CCDC 2054231: Experimental Crystal Structure Determination(2021)
- → Balancing the Dual Mechanisms of Anti-VISTA mAbs for Anti-Tumor Activity: CD8+ T Cell Responses and Fc-dependent Depletion of VISTA-Expressing Immune Cells(2026)
- → Abstract LB425: A tumor microenvironment-targeting CD98-directed ADC confers robust anti-tumor activity in multiple cancers with favorable pharmacokinetics and safety profiles in preclinical models(2024)